Low Frequency of CXCR4-Using Viruses in Patients at the Time of Primary Non-Subtype-B HIV-1 Infection

ABSTRACT We used genotypic and phenotypic assays to estimate the frequency of X4/DM viruses in 131 patients infected with non-subtype-B viruses at the time of primary HIV-1 infection (PHI). All patients were enrolled in the French PRIMO Cohort from 1996 to 2007. Most strains belonged to CRF02_AG (51.1%) and subtype A (14.5%). Sixteen viruses (12.2%) were classified as CXCR4 tropic (“X4 strains”) by the combined criteria of amino acids 11 and 25 of the V3 loop (11/25) and net charge rules and/or the SVMgeno2pheno10% algorithm: 6 strains by the combined genotypic rule, 7 by the SVMgeno2pheno10% algorithm, and 3, clustering in subtype D, by both algorithms. However, only one strain (0.8%), belonging to subtype A, was defined as a dual-tropic (DM) virus by the phenotypic assay. The 67 CRF02_AG strains included 2 classified as X4 strains by the combined genotypic rule (3%) and 2 others classified as X4 strains by SVMgeno2pheno10% (3%), but none of these 4 strains was an X4 or DM strain according to the phenotypic assay. These results suggest that the cellular virus reservoir was established with X4 strains in very few non-subtype-B-infected patients at the time of PHI. Genotypic predictions can overestimate the proportion of non-subtype-B X4 viruses at PHI.

[1]  L. Ferradini,et al.  Prediction of HIV Type 1 Subtype C Tropism by Genotypic Algorithms Built From Subtype B Viruses , 2010, Journal of acquired immune deficiency syndromes.

[2]  P. Massip,et al.  Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[3]  Shungao Xu,et al.  Predicted co-receptor tropism and sequence characteristics of China HIV-1 V3 loops: implications for the future usage of CCR5 antagonists and AIDS vaccine development. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  C. Rouzioux,et al.  High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study. , 2009, The Journal of antimicrobial chemotherapy.

[5]  P. Massip,et al.  Genotypic Prediction of Human Immunodeficiency Virus Type 1 CRF02-AG Tropism , 2009, Journal of Clinical Microbiology.

[6]  Natalia Chueca,et al.  Improvement in the determination of HIV‐1 tropism using the V3 gene sequence and a combination of bioinformatic tools , 2009, Journal of medical virology.

[7]  C. Delaugerre,et al.  Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996–2006 in France , 2009, AIDS.

[8]  Paolo Piazza,et al.  Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study. , 2008, The Journal of infectious diseases.

[9]  L. Cuzin,et al.  Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism , 2008, AIDS.

[10]  Steven Wolinsky,et al.  Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues. , 2008, AIDS research and human retroviruses.

[11]  M. Peeters,et al.  New and old complex recombinant HIV-1 strains among patients with primary infection in 1996–2006 in France: The French ANRS CO06 primo cohort study , 2008, Retrovirology.

[12]  E. Poveda,et al.  Performance of a Population-Based HIV-1 Tropism Phenotypic Assay and Correlation With V3 Genotypic Prediction Tools in Recent HIV-1 Seroconverters , 2008, Journal of Acquired Immune Deficiency Syndromes.

[13]  Wei Huang,et al.  HIV-1 tropism and survival in vertically infected Ugandan infants. , 2008, The Journal of infectious diseases.

[14]  C. Petropoulos,et al.  Coreceptor Tropism Can Be Influenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeficiency Virus Type 1 Envelope Protein , 2008, Journal of Virology.

[15]  T. Klimkait,et al.  HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy , 2008, AIDS.

[16]  Natalia Chueca,et al.  Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes , 2008, Journal of Clinical Microbiology.

[17]  Tobias Sing,et al.  Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates , 2007, AIDS.

[18]  M. Chesney,et al.  Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection , 2007, AIDS.

[19]  Wei Huang,et al.  Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations , 2007, Journal of Virology.

[20]  P. Kaleebu,et al.  Relation Between Chemokine Receptor Use, Disease Stage, and HIV-1 Subtypes A and D: Results From a Rural Ugandan Cohort , 2007, Journal of acquired immune deficiency syndromes.

[21]  L. Ruiz,et al.  Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. , 2007, The Journal of antimicrobial chemotherapy.

[22]  Christophe Pasquier,et al.  Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies , 2007, Journal of Clinical Microbiology.

[23]  Tobias Sing,et al.  Determining Human Immunodeficiency Virus Coreceptor Use in a Clinical Setting: Degree of Correlation between Two Phenotypic Assays and a Bioinformatic Model , 2006, Journal of Clinical Microbiology.

[24]  Christos J. Petropoulos,et al.  Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism , 2006, Antimicrobial Agents and Chemotherapy.

[25]  David W. Williamson,et al.  Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. , 2006, The Journal of infectious diseases.

[26]  T. Ndung’u,et al.  HIV-1 subtype C in vitro growth and coreceptor utilization. , 2006, Virology.

[27]  P. Morlat,et al.  CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  C. Rouzioux,et al.  HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time , 2006, AIDS.

[29]  P. Harrigan,et al.  Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals. , 2005, The Journal of infectious diseases.

[30]  B. Gazzard,et al.  Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection. , 2005, The Journal of infectious diseases.

[31]  John P. Moore,et al.  The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. , 2004, AIDS research and human retroviruses.

[32]  M. Bomsel,et al.  Mucosal gatekeepers: Selecting HIV viruses for early infection , 2002, Nature Medicine.

[33]  Eric Delwart,et al.  Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection , 2002, AIDS.

[34]  J. Sleasman,et al.  Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages). , 2000, AIDS.

[35]  J. Margolick,et al.  Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study , 2000, AIDS.

[36]  J. Albert,et al.  Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. , 1999, AIDS research and human retroviruses.

[37]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[38]  J. Albert,et al.  Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. , 1998, Virology.

[39]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[40]  D. Ho,et al.  HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism. , 1997, AIDS research and human retroviruses.

[41]  B. Chesebro,et al.  Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes , 1996, Journal of virology.

[42]  Roderic D. M. Page,et al.  TreeView: an application to display phylogenetic trees on personal computers , 1996, Comput. Appl. Biosci..

[43]  E. G. Shpaer,et al.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. , 1993, Science.

[44]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[45]  I. Keet,et al.  Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.

[46]  J. Goudsmit,et al.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.

[47]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.